BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1977771)

  • 1. Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia.
    Storr J; Dolan G; Coustan-Smith E; Barnett D; Reilly JT
    J Clin Pathol; 1990 Oct; 43(10):847-9. PubMed ID: 1977771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
    Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
    Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
    Seshi B; Kashyap A; Bennett JM
    Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry.
    Larson RS; McCurley TL
    Am J Clin Pathol; 1995 Aug; 104(2):204-11. PubMed ID: 7543728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
    Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
    Leuk Lymphoma; 2001 Aug; 42(4):675-82. PubMed ID: 11697497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry.
    Buccheri V; Shetty V; Yoshida N; Morilla R; Matutes E; Catovsky D
    Br J Haematol; 1992 Jan; 80(1):62-8. PubMed ID: 1311196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
    Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
    Leuk Lymphoma; 2001 Jun; 42(1-2):75-82. PubMed ID: 11699224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
    Leong CF; Kalaichelvi AV; Cheong SK; Hamidah NH; Rahman J; Sivagengei K
    Malays J Pathol; 2004 Dec; 26(2):111-6. PubMed ID: 16329563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable detection of myeloid antigens in childhood acute lymphoblastic leukaemia.
    Howard MR; Thomas L; Reid MM
    J Clin Pathol; 1994 Nov; 47(11):1006-9. PubMed ID: 7829673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
    Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
    Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of myeloperoxidase by flow cytometry in acute leukemia.
    Nakase K; Sartor M; Bradstock
    Cytometry; 1998 Aug; 34(4):198-202. PubMed ID: 9725460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
    Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
    Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia.
    van der Schoot CE; Daams GM; Pinkster J; Vet R; von dem Borne AE
    Br J Haematol; 1990 Feb; 74(2):173-8. PubMed ID: 2156549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of myeloid or lymphoid acute leukemia by a chemiluminescence assay. Comparison with immunocytochemistry using an antimyeloperoxidase antibody.
    da Fonseca LM; Brunetti IL; Rego EM; Garcia AB; Cilento G; Falcão RP
    Acta Haematol; 1993; 90(1):19-24. PubMed ID: 8237269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of CD33 with poorer prognosis in childhood ALL implicates a potential of anti-CD33 frontline therapy.
    Mejstríková E; Kalina T; Trka J; Starý J; Hrusák O
    Leukemia; 2005 Jun; 19(6):1092-4. PubMed ID: 15830012
    [No Abstract]   [Full Text] [Related]  

  • 17. Acquisition of CD13 and CD33 expression at relapse on acute myeloid leukemia cells with an unusual phenotype: MPO+CD13-CD33-.
    Kawada H; Ichikawa Y; Kobayashi N; Fukuda R; Yonekura S; Nagao T
    Intern Med; 1993 Sep; 32(9):733-6. PubMed ID: 7908235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and ultrastructural studies in acute biphenotypic leukaemia.
    Shetty V; Chitale A; Matutes E; Buccheri V; Morilla R; Catovsky D
    J Clin Pathol; 1993 Oct; 46(10):903-7. PubMed ID: 8227405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia M2 and t(8;21)(q22;q22) with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-), and CD33(-).
    García Vela JA; Martin M; Delgado I; García Alonso L; Monteserin MC; Benito L; Somolinos N; Oña F
    Ann Hematol; 1999 May; 78(5):237-40. PubMed ID: 10391105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19.
    Mizutani M; Miwa H; Takahashi T; Katoh K; Shikami M; Katayama N; Shiku H; Kita K
    Int J Hematol; 1997 Dec; 66(4):479-91. PubMed ID: 9479874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.